Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

References

• Hui DS EIA, Madani TA, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264–266. doi: 10.1016/j.ijid.2020.01.009
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. doi: 10.1056/NEJMoa2001316
   Web of Science ®Google Scholar
• Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020. doi: 10.1001/jama.2020.1097
   Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar
• Chan JF, Kok KH, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microb Infect. 2020;9(1):221–236. doi: 10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–423. doi: 10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Wu A, Peng Y, Huang B, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325–328. doi: 10.1016/j.chom.2020.02.001
   PubMed Web of Science ®Google Scholar
• Jiang S, He Y, Liu S. SARS vaccine development. Emerg Infect Dis. 2005;11(7):1016–1020. doi: 10.3201/1107.050219
   PubMed Web of Science ®Google Scholar
• Du L, He Y, Zhou Y, et al. The spike protein of SARS-CoV – a target for vaccine and therapeutic development. Nat Rev Microbiol. 2009;7(3):226–236. doi: 10.1038/nrmicro2090
   PubMed Web of Science ®Google Scholar
• Roper RL, Rehm KE. SARS vaccines: where are we? Expert Rev Vaccines. 2009;8(7):887–898. doi: 10.1586/erv.09.43
   PubMed Web of Science ®Google Scholar
• Enjuanes L, Zuniga S, Castano-Rodriguez C, et al. Molecular basis of coronavirus virulence and vaccine development. Adv Virus Res. 2016;96:245–286. doi: 10.1016/bs.aivir.2016.08.003
   PubMed Web of Science ®Google Scholar
• Fan C, Wu X, Liu Q, et al. A human DPP4-Knockin mouse’s susceptibility to infection by authentic and pseudotyped MERS-CoV. Viruses. 2018;10(9):448. doi: 10.3390/v10090448
   Web of Science ®Google Scholar
• Nie J, Wu X, Ma J, et al. Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system. Sci Rep. 2017;7:42769. doi: 10.1038/srep42769
   PubMed Web of Science ®Google Scholar
• Liu Q, Fan C, Li Q, et al. Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection. Sci Rep. 2017;7:45552. doi: 10.1038/srep45552
   PubMed Web of Science ®Google Scholar
• Zhang L, Li Q, Liu Q, et al. A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system. Hum Vaccin Immunother. 2017;13(8):1811–1817. doi: 10.1080/21645515.2017.1325050
   PubMed Web of Science ®Google Scholar
• Li Q, Liu Q, Huang W, et al. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions. Vaccine. 2017;35(38):5172–5178. doi: 10.1016/j.vaccine.2017.07.101
   PubMed Web of Science ®Google Scholar
• Wu J, Zhao C, Liu Q, et al. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine. 2017;35(47):6387–6394. doi: 10.1016/j.vaccine.2017.10.007
   PubMed Web of Science ®Google Scholar
• Nie J, Liu L, Wang Q, et al. Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities. Emerg Microbes Infect. 2019;8(1):272–281. doi: 10.1080/22221751.2019.1571871
   PubMed Web of Science ®Google Scholar
• Ma J, Chen R, Huang W, et al. In vitro and in vivo efficacy of a Rift valley fever virus vaccine based on pseudovirus. Hum Vaccin Immunother. 2019;15(10):2286–2294. doi: 10.1080/21645515.2019.1627820
   PubMed Web of Science ®Google Scholar
• Whitt MA. Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virol Methods. 2010;169(2):365–374. doi: 10.1016/j.jviromet.2010.08.006
   PubMed Web of Science ®Google Scholar
• Chen Q, Nie J, Huang W, et al. Development and optimization of a sensitive pseudovirus-based assay for HIV-1 neutralizing antibodies detection using A3R5 cells. Hum Vaccin Immunother. 2018;14(1):199–208. doi: 10.1080/21645515.2017.1373922
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Kuo CC, Chiang AW, Shamie I, et al. The emerging role of systems biology for engineering protein production in CHO cells. Curr Opin Biotechnol. 2018;51:64–69. doi: 10.1016/j.copbio.2017.11.015
   PubMed Web of Science ®Google Scholar
• Nakamura K, Harada Y, Takahashi H, et al. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus. Vaccine. 2019;37(43):6526–6534. doi: 10.1016/j.vaccine.2019.08.064
   PubMed Web of Science ®Google Scholar
• Hofmann H, Hattermann K, Marzi A, et al. S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol. 2004;78(12):6134–6142. doi: 10.1128/JVI.78.12.6134-6142.2004
   PubMed Web of Science ®Google Scholar
• Li Q, Liu Q, Huang W, et al. Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol. 2018 Jan;28(1):e1963. doi:10.1002/rmv.1963.
   Web of Science ®Google Scholar
• Nie J, Huang W, Liu Q, et al. HIV-1 pseudoviruses constructed in China regulatory laboratory. Emerg Microb Infect. 2020;9(1):32–41. doi: 10.1080/22221751.2019.1702479
   PubMed Web of Science ®Google Scholar